Osteoanabolics

Osteoporosis is characterized by reduced bone mass, impaired bone quality, and a propensity to fracture. An "osteoanabolic" should be referred to any therapy that helps increase bone mass. Bone mass represents 80% of bone mechanical strength. A low bone mass therefore provides the stronges...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Vishal, Shah, Mitul Abhaykumar, Shah, Sagar Kirtibhai, Shah, Jinen Mukeshbhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354839/
https://www.ncbi.nlm.nih.gov/pubmed/22629498
http://dx.doi.org/10.4103/2230-8210.95662
_version_ 1782233280322469888
author Gupta, Vishal
Shah, Mitul Abhaykumar
Shah, Sagar Kirtibhai
Shah, Jinen Mukeshbhai
author_facet Gupta, Vishal
Shah, Mitul Abhaykumar
Shah, Sagar Kirtibhai
Shah, Jinen Mukeshbhai
author_sort Gupta, Vishal
collection PubMed
description Osteoporosis is characterized by reduced bone mass, impaired bone quality, and a propensity to fracture. An "osteoanabolic" should be referred to any therapy that helps increase bone mass. Bone mass represents 80% of bone mechanical strength. A low bone mass therefore provides the strongest association of future risk of fracture. This review aims to discuss all available and future therapies that attempt to increase bone mass be it organic or inorganic.
format Online
Article
Text
id pubmed-3354839
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33548392012-05-24 Osteoanabolics Gupta, Vishal Shah, Mitul Abhaykumar Shah, Sagar Kirtibhai Shah, Jinen Mukeshbhai Indian J Endocrinol Metab Review Article Osteoporosis is characterized by reduced bone mass, impaired bone quality, and a propensity to fracture. An "osteoanabolic" should be referred to any therapy that helps increase bone mass. Bone mass represents 80% of bone mechanical strength. A low bone mass therefore provides the strongest association of future risk of fracture. This review aims to discuss all available and future therapies that attempt to increase bone mass be it organic or inorganic. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3354839/ /pubmed/22629498 http://dx.doi.org/10.4103/2230-8210.95662 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Gupta, Vishal
Shah, Mitul Abhaykumar
Shah, Sagar Kirtibhai
Shah, Jinen Mukeshbhai
Osteoanabolics
title Osteoanabolics
title_full Osteoanabolics
title_fullStr Osteoanabolics
title_full_unstemmed Osteoanabolics
title_short Osteoanabolics
title_sort osteoanabolics
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354839/
https://www.ncbi.nlm.nih.gov/pubmed/22629498
http://dx.doi.org/10.4103/2230-8210.95662
work_keys_str_mv AT guptavishal osteoanabolics
AT shahmitulabhaykumar osteoanabolics
AT shahsagarkirtibhai osteoanabolics
AT shahjinenmukeshbhai osteoanabolics

Ejemplares similares